AI leadership, strong growth guidance, and undervalued shares offer major upside. Click here to read my analysis.
Abeona Therapeutics is at a critical juncture, trading near 52-week lows ahead of its first ZEVASKYN revenue update in Q3.
Quantum mechanics has at last been formulated exclusively with real numbers, bringing a mathematical puzzle at the heart of ...
Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and metastatic lesions MP0712 Radio-DARPin leverages rapid intern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback